Veteran pediatrician hails Medicaid shift ending youth sex-change treatments: 'This is not denial of care'

A pediatric endocrinologist who's been treating kids for decades looks at the evidence and says the framework behind youth gender medicine is falling apart. That's not a talking point from a campaign ad. That's someone who reads bloodwork for a living telling you the science got ahead of itself, and now Medicaid is catching up to what the data actually shows.

The phrase "denial of care" has been doing a lot of work in this debate, and it's worth sitting with why Van Meter rejects it. Denial of care implies you're withholding something proven to help. What we've watched instead, over the last several years, is European health systems, the ones we're constantly told to emulate, quietly pulling back on puberty blockers and cross-sex hormones for minors after their own reviews found the evidence thin. Sweden, Finland, the UK's own NHS review all moved before American Medicaid did. That's not America lagging behind enlightened medicine. That's America finally listening to it.

None of this means the underlying kids and families are less real or less struggling. They are. But conflating compassion with a specific irreversible medical pathway was always the sleight of hand here, and it's telling that the people raising alarms loudest are often the ones with the least clinical skin in the game. Van Meter has spent a career in endocrinology. His caution should carry more weight than a press release.

What this policy shift really represents is a system admitting it moved too fast on too little proof, for a population too young to weigh permanent consequences. That's not cruelty. That's medicine doing what medicine is supposed to do when the science wobbles: slow down.